Genurin Forte Tablets contain 200 mg of flavoxate hydrochloride per sugar- coated tablet. Flavoxate is an original product of Recordati research. It exerts a marked anti- spasmodic activity on the smooth muscle of the urogenital tract. Genurin Semplice type “Forte” is indicated for the treatment of symptoms of various urological and gynecological disorders, particularly in resistant of relapsing cases.
- Treatment of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence in vesical and prostatic infections, such as, cystitis, cystalgia, prostatis, urethritis, urethrocystitis, urethrotrigonitis
- As an adjuvant in the antispasmodic treatment of renal and uretheral lithiasis and urinary; spastic disorders caused by catherterization and cystoscopy. Sequelae of surgery on the lower urinary tract
- Treatment of spastic states in female genital tract, such as pelvic algias, dysmenorrhoea. uterine hypertonia and dyskinesia
Genurin Forte is contra-indicated in patients with the following conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus achalasia, gastrointestinal haemorrhage, uncompensated obstructive uropathies of the lower urinary tract.
In patients with concomitant infections of urogenital tract, flavoxate should be administered in combination with an adequate anti-infective therapy, Even though the compound exerts no appreciable anti-cholinergic action, it is appropriate to use it carefully in patients with glaucoma, especially in closed-angle forms. Patients under treatment driving cars, operating machinery of exerting activities requiring alertness, should be warned about the possible side-effects, such as drowsiness or blurred vision.